FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to otolaryngology, and can be applied for treatment of chronic pharyngitis. For this purpose intranasallly solution, which contains novocaine and lazolvan, is introduced.
EFFECT: invention ensures efficient treatment of said diseases due to stimulation of local antivirus protection, suppression of non-residential microflora vegetation on mucous tunic of gullet, anti-edematous and anti-inflammatory action.
4 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC PHARYNGITIS | 2009 |
|
RU2394565C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS | 2020 |
|
RU2736046C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS WITH NOVOCAINE AND MEXIDOL SOLUTION | 2009 |
|
RU2394567C1 |
METHOD OF TREATING (THERAPY OF) COMPENSATED NON-SPECIFIC CHRONIC TONSILLITIS | 2012 |
|
RU2510749C1 |
METHOD OF TREATING ANGINA ACUTA (ACUTE TONSILLITIS) | 2011 |
|
RU2456986C1 |
METHOD FOR PREVENTION OF AGGRAVATED RECURRENT RHINOSINUSITIS | 2013 |
|
RU2562537C2 |
LIQUID WATER PHARMACEUTICAL COMPOSITION OF AMBROXOL AND PHARMACEUTICAL PREPARATION BASED ON IT, INTENDED FOR TREATING DISEASES OF RESPIRATORY WAYS WITH FORMATION OF VISCOUS SPUTUM (VERSIONS) | 2010 |
|
RU2426531C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS | 2015 |
|
RU2602692C1 |
METHOD FOR TREATING THE CASES OF PHARYNGITIS | 2001 |
|
RU2198704C1 |
METHOD OF CHRONIC ATROPHIC PHARYNGITIS MEDICAL TREATMENT | 2006 |
|
RU2326661C1 |
Authors
Dates
2010-07-20—Published
2009-03-17—Filed